From: Good practices for 68Ga radiopharmaceutical production
Test | Specifications [68Ga]Ga-DOTA-TOC | Specifications [68Ga]Ga-PSMA-11 (In Ph. Eur. 10.4, 3044) | Method |
---|---|---|---|
Appearance | Clear, colourless solution | Clear, colourless solution | Visual |
pH | 4–8 | 4–8 | pH strips |
Endotoxins |  < 175I.E./V (maximal dose in mL) |  < 175I.E./V (maximal dose in mL) |  |
Radiochemical identity and Purity |  > 91% overall purity Colloidal 68Ga: < 3% |  > 95% overall purity Colloidal 68Ga: < 3% | TLC |
 | Free 68GaCl3: < 2% |  > 95% overall purity | HPLC |
Radionuclidic identity | 0.511Â MeV, 1.077Â MeV, sum peak 1.022Â MeV | 0.511Â MeV, 1.077Â MeV, sum peak 1.022Â MeV | Gamma spectrometry |
 | 62 – 74 min | 61 – 75 min | Half-life |
Radio nuclidic purity | 68Ge < 0.001% | 68Ge < 0.001% | Gamma spectrometry |
Residual solvents | Ethanol max. 10% (V/V) or 2.5Â g/dose | Ethanol max. 10% (V/V) or 2.5Â g/dose | GC |
Chemical Purity | Edotreotide, Galliumedotreotide, others  < 50 µg/V | PSMA-11, gallium PSMA-11, others < 30 µg/V | HPLC 220 nm detection (DOTA-TOC), 280 nm (PSMA-11) |
 | HEPES < 200 µg/V | HEPES < 500 µg/V | TLC |
Sterility | Sterile | Sterile | Membrane filtration |